JP2023533504A5 - - Google Patents

Info

Publication number
JP2023533504A5
JP2023533504A5 JP2022581467A JP2022581467A JP2023533504A5 JP 2023533504 A5 JP2023533504 A5 JP 2023533504A5 JP 2022581467 A JP2022581467 A JP 2022581467A JP 2022581467 A JP2022581467 A JP 2022581467A JP 2023533504 A5 JP2023533504 A5 JP 2023533504A5
Authority
JP
Japan
Application number
JP2022581467A
Other languages
Japanese (ja)
Other versions
JP2023533504A (ja
JPWO2022010942A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040576 external-priority patent/WO2022010942A2/en
Publication of JP2023533504A publication Critical patent/JP2023533504A/ja
Publication of JP2023533504A5 publication Critical patent/JP2023533504A5/ja
Publication of JPWO2022010942A5 publication Critical patent/JPWO2022010942A5/ja
Priority to JP2025173218A priority Critical patent/JP2026016462A/ja
Pending legal-status Critical Current

Links

JP2022581467A 2020-07-07 2021-07-06 バイオフィルムの処置および予防のための併用療法 Pending JP2023533504A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025173218A JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063049065P 2020-07-07 2020-07-07
US63/049,065 2020-07-07
US202163175487P 2021-04-15 2021-04-15
US63/175,487 2021-04-15
PCT/US2021/040576 WO2022010942A2 (en) 2020-07-07 2021-07-06 Combination therapies for the treatment and prevention of biofilms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025173218A Division JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Publications (3)

Publication Number Publication Date
JP2023533504A JP2023533504A (ja) 2023-08-03
JP2023533504A5 true JP2023533504A5 (https=) 2024-05-28
JPWO2022010942A5 JPWO2022010942A5 (https=) 2024-05-28

Family

ID=79553736

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022581467A Pending JP2023533504A (ja) 2020-07-07 2021-07-06 バイオフィルムの処置および予防のための併用療法
JP2025173218A Pending JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025173218A Pending JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Country Status (7)

Country Link
US (1) US20230272054A1 (https=)
EP (1) EP4178359A4 (https=)
JP (2) JP2023533504A (https=)
CN (1) CN116096239B (https=)
AU (1) AU2021305167A1 (https=)
CA (1) CA3183196A1 (https=)
WO (1) WO2022010942A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120230733B (zh) * 2025-06-03 2025-07-29 山东三元生物科技股份有限公司 一种基于Spytag/SpyCatcher环化修饰的蔗糖磷酸化酶突变体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012010793A (es) * 2010-03-29 2013-05-09 Univ Southern California Composiciones y metodos para la eliminacion de biopeliculas.
US10722577B2 (en) * 2012-05-25 2020-07-28 Sloan Kettering Institute For Cancer Research Methods for treating GI syndrome and graft versus host disease
US20160340650A1 (en) * 2015-05-21 2016-11-24 Batu Biologics, Inc. Blood derived immune stimulatory compositions
JP7514621B2 (ja) * 2017-01-04 2024-07-11 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル Dnabiiワクチンおよび強化された活性を有する抗体
AU2018236271B2 (en) * 2017-03-15 2023-12-21 Research Institute At Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation
US20210139610A1 (en) * 2018-06-29 2021-05-13 Research Institute At Nationwide Children's Hospital Compositions and methods for mediating eps
WO2020038963A1 (en) * 2018-08-21 2020-02-27 Modiquest B.V. Antibodies binding to citrullinated histone 2a and/or 4
SG11202103001PA (en) * 2018-10-05 2021-04-29 Res Inst Nationwide Childrens Hospital Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
EA202191176A1 (ru) * 2018-10-31 2021-07-28 Делиниа, Инк. Поливалентные модуляторы регуляторных т-клеток
WO2021007260A2 (en) * 2019-07-08 2021-01-14 Research Institute At Nationwide Children's Hospital Antibody compositions for disrupting biofilms

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022540083A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)